| MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation SK Surapaneni, ZR Bhat, K Tikoo Scientific reports 10 (1), 17954, 2020 | 27 | 2020 |
| Synthesis and evaluation of new 1, 2, 4-oxadiazole based trans-acrylic acid derivatives as potential PPAR-alpha/gamma dual agonist P Kaur, ZR Bhat, S Bhat, R Kumar, R Kumar, K Tikoo, J Gupta, N Khurana, ... Bioorganic Chemistry 100, 103867, 2020 | 25 | 2020 |
| Role of autophagy and histone deacetylases in diabetic nephropathy: Current status and future perspectives S Khan, ZR Bhat, G Jena Genes & Diseases 3 (3), 211-219, 2016 | 19 | 2016 |
| Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment M Kumar, G Joshi, S Arora, T Singh, S Biswas, N Sharma, ZR Bhat, ... Molecules 26 (5), 1490, 2021 | 16 | 2021 |
| Cereal proteins C Sudheesh, ZR Bhat, B Aaliya, KV Sunooj Nutraceuticals and Health Care, 29-60, 2022 | 8 | 2022 |
| Advancements of Nanotechnology in Diagnostic Applications Z Rafiq, P Patel, S Kumar, HS Sofi, J Macossay, FA Sheikh Application of Nanotechnology in Biomedical Sciences, 1-15, 2020 | 5 | 2020 |
| Ascorbic acid B Mittu, ZR Bhat, A Chauhan, J Kour, A Behera, M Kaur Nutraceuticals and Health Care, 289-302, 2022 | 3 | 2022 |
| In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor … ZR Bhat, M Kumar, N Sharma, UP Yadav, T Singh, G Joshi, B Pujala, ... Molecules 27 (17), 5540, 2022 | 2 | 2022 |
| Removal and Detoxification of Aflatoxins ZR Bhat, KR Hakeem Aflatoxins in Food: A Recent Perspective, 195-205, 2022 | 2 | 2022 |
| Resveratrol ZR Bhat, A Bhat, B Mittu, KV Sunooj, RU Zaman Nutraceuticals and Health Care, 217-231, 2022 | 1 | 2022 |
| Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy Y Hu, A Revenko, H Barsoumian, G Bertolet, NW Fowlkes, H Maazi, ... Journal of Experimental & Clinical Cancer Research 43 (1), 70, 2024 | | 2024 |
| Potentially active aspirin derivative to release nitric oxide: In-vitro, in-vivo and in-silico approaches AM Amritkar, A Hussain, MA Altamimi, S Ashique, MUM Siddique, S Burle, ... Saudi Pharmaceutical Journal 32 (3), 101925, 2024 | | 2024 |
| Target validation and structure-based virtual screening to Discover potential lead molecules against the oncogenic NSD1 histone methyltransferase ZR Bhat, A Gahlawat, N Kumar, N Sharma, P Garg, K Tikoo In Silico Pharmacology 11 (1), 21, 2023 | | 2023 |
Raj Kumar, FRSCProfessor of Medicinal/Pharmaceutical Chemistry, Central University of PunjabVerified email at cup.edu.in
